FTSE All-Share
4.449,61
PKT
+20,88
PKT
+0,47
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.06.24 | BAT Neutral | UBS AG | |
| 04.06.24 | AstraZeneca Sell | UBS AG | |
| 04.06.24 | BAT Sector Perform | RBC Capital Markets | |
| 04.06.24 | GSK Buy | Deutsche Bank AG | |
| 04.06.24 | Diageo Sell | UBS AG | |
| 04.06.24 | GSK Buy | Jefferies & Company Inc. | |
| 03.06.24 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 03.06.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 03.06.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.06.24 | GSK Buy | Deutsche Bank AG | |
| 03.06.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 03.06.24 | National Grid Market-Perform | Bernstein Research | |
| 31.05.24 | National Grid Outperform | RBC Capital Markets | |
| 31.05.24 | National Grid Buy | Jefferies & Company Inc. | |
| 31.05.24 | HSBC Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.05.24 | Unilever Sector Perform | RBC Capital Markets | |
| 30.05.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 30.05.24 | BAT Buy | Jefferies & Company Inc. | |
| 30.05.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 29.05.24 | National Grid Buy | UBS AG | |
| 28.05.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.05.24 | National Grid Outperform | RBC Capital Markets | |
| 24.05.24 | National Grid Market-Perform | Bernstein Research | |
| 24.05.24 | National Grid Neutral | Goldman Sachs Group Inc. | |
| 23.05.24 | National Grid Outperform | RBC Capital Markets | |
| 23.05.24 | National Grid Neutral | Goldman Sachs Group Inc. | |
| 23.05.24 | National Grid Buy | UBS AG | |
| 23.05.24 | National Grid Outperform | RBC Capital Markets | |
| 23.05.24 | National Grid Overweight | JP Morgan Chase & Co. | |
| 23.05.24 | Vodafone Group Buy | Goldman Sachs Group Inc. | |
| 23.05.24 | BAT Neutral | UBS AG | |
| 23.05.24 | Unilever Overweight | JP Morgan Chase & Co. | |
| 22.05.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 22.05.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 21.05.24 | BAT Buy | Deutsche Bank AG | |
| 21.05.24 | BP Buy | UBS AG | |
| 21.05.24 | AstraZeneca Sell | UBS AG | |
| 21.05.24 | Unilever Market-Perform | Bernstein Research | |
| 20.05.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 20.05.24 | BAT Neutral | UBS AG |